Related references
Note: Only part of the references are listed.Inflammatory myofibroblastic tumor: The experience of the European pediatric Soft Tissue Sarcoma Study Group (EpSSG)
Michela Casanova et al.
EUROPEAN JOURNAL OF CANCER (2020)
The Activity of Chemotherapy in Inflammatory Myofibroblastic Tumors: A Multicenter, European Retrospective Case Series Analysis
Giacomo Giulio Baldi et al.
ONCOLOGIST (2020)
Expanding the Molecular Characterization of Thoracic Inflammatory Myofibroblastic Tumors beyond ALK Gene Rearrangements
Jason C. Chang et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Inflammatory myofibroblastic tumor: A demographic, clinical and therapeutic study of 92 cases
Guoxiang Fu et al.
MATHEMATICAL BIOSCIENCES AND ENGINEERING (2019)
Crizotinib in ALK+ inflammatory myofibroblastic tumors-Current experience and future perspectives
Till-Martin Theilen et al.
PEDIATRIC BLOOD & CANCER (2018)
Inflammatory myofibroblastic tumorsA retrospective analysis of the Cooperative Weichteilsarkom Studiengruppe
Stefanie Kube et al.
PEDIATRIC BLOOD & CANCER (2018)
Pulmonary inflammatory Myofibroblastic Tumor in Children: A Case Report and Brief Review of Literature
Federica Camela et al.
FRONTIERS IN PEDIATRICS (2018)
Surgical Treatment of Childhood Inflammatory Myofibroblastic Tumors
Tutku Soyer et al.
EUROPEAN JOURNAL OF PEDIATRIC SURGERY (2017)
Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study
Yael P. Mosse et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Clinicopathological Study of 18 Cases of Inflammatory Myofibroblastic Tumors with Reference to ALK-1 Expression: 5-Year Experience in a Tertiary Care Center
Ramesh Babu Telugu et al.
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2017)
Analysis of clinical features and outcomes for inflammatory myofibroblastic tumors in China: 11 years of experience at a single center
Zuopeng Wang et al.
PEDIATRIC SURGERY INTERNATIONAL (2016)
Neoadjuvant Treatment With Cyclooxygenase-2 Inhibitor and Prednisolone Allows Conservative Surgery for Inflammatory Myofibroblastic Tumor of the Bladder
Yusuke Tsuma et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2016)
Inflammatory myofibroblastic tumors in children
Brian G. A. Dalton et al.
JOURNAL OF PEDIATRIC SURGERY (2016)
Remission of ALK-negative primary pulmonary inflammatory myofibroblastic tumor on treatment with clarithromycin: A case report and review of the literature
Hidehiro Watanabe et al.
ONCOLOGY LETTERS (2016)
Intra-abdominal inflammatory myofibroblastic tumor: Spontaneous regression
Jun-Jie Zhao et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Inflammatory Myofibroblastic Tumors Harbor Multiple Potentially Actionable Kinase Fusions
Christine M. Lovly et al.
CANCER DISCOVERY (2014)
Complete remission of ALK-negative plasma cell granuloma (inflammatory myofibroblastic tumor) of the lung induced by celecoxib: A case report and review of the literature
Cinderella Chavez et al.
ONCOLOGY LETTERS (2013)
Epithelioid Inflammatory Myofibroblastic Sarcoma: An Aggressive Intra-abdominal Variant of Inflammatory Myofibroblastic Tumor With Nuclear Membrane or Perinuclear ALK
Adrian Marino-Enriquez et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
The Clavien-Dindo Classification of Surgical Complications Five-Year Experience
Pierre A. Clavien et al.
ANNALS OF SURGERY (2009)
Pediatric inflammatory myofibroblastic tumor: Anaplastic lymphoma kinase (ALK) expression and prognosis
YS Chun et al.
PEDIATRIC BLOOD & CANCER (2005)
The rationale for nonsteroidal anti-inflammatory drug therapy for inflammatory myofibroblastic tumors: a Children's Oncology Group study
H Applebaum et al.
JOURNAL OF PEDIATRIC SURGERY (2005)
Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor - A comparative immunohistochemical study
JR Cook et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2001)
TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors
B Lawrence et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
